Dr Lal PathLabs share price slipped over 6 percent on October 24 amid profit booking after the diagnostics firm said its consolidated profit after tax increased 18 percent on-year to Rs 131 crore for the second quarter ended September 30, 2024. The company had reported a profit after tax (PAT) of Rs 111 crore in the July-September quarter of last fiscal year.
Revenue increased to Rs 660 crore in the second quarter of this fiscal, as compared to Rs 601 crore in the year-ago period, the company said in an exchange filing.
Dr Lal PathLabs stock touched an intraday low of Rs 3041.05 per share on the NSE, declining 6.59 percent from its previous close. The counter has been losing for the last two days and has fallen 7.34 percent in the period. At the time of publishing, the stock was down to quote at Rs 3,060.15 apiece on the NSE, down 6.01 percent.
The company board also approved a second interim dividend of Rs 6 per equity share for the financial year 2024-25.
Dr Lal PathLabs shares rose 20.51 percent in 2024 so far, against the 10.81 percent rise in the benchmark Sensex for the same period.
Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
